MRI可见外周带病灶PI-RADS v2.1升级规则亚分类的可重复性有限
本回顾性单中心研究纳入310例患者共375个MRI可见外周带病灶,均行3T多参数MRI及MRI-TRUS融合靶向活检。3名放射科医师独立按PI-RADS v2.1重新评分,评估PI-RADS 4升级亚分类的观察者间一致性及其与临床有意义前列腺癌检出率的关系。结果显示该亚分类可重复性仅为一般至中等,升级与非升级病灶的csPCa检出率差异因阅片者而异。
要点
- PI-RADS 4升级亚分类的观察者间一致性仅为一般至中等(AC1 0.29-0.57)
- 非升级PI-RADS 4病灶csPCa检出率总体上高于升级病灶
- 升级亚分类与csPCa的关联强度因阅片者不同而变化,解读需谨慎
核心结论
- PI-RADS v2.1升级规则中亚分类PI-RADS 4病灶的可重复性有限
- 非升级PI-RADS 4病灶通常显示较高的csPCa检出率,但亚组特异性估计因阅片者而异
- 支持对PI-RADS 4升级亚分类的解读持谨慎态度
研究设计与样本
- 回顾性单中心病灶水平研究,纳入310例患者共375个MRI可见外周带病灶
- 检查设备为3T多参数MRI,活检方法为MRI-TRUS融合靶向活检
- 3名放射科医师独立按PI-RADS v2.1对预定位病灶重新评分
- csPCa定义为ISUP分级组≥2,使用广义估计方程处理患者内病灶聚集
关键影像表现/征象
- PI-RADS 4病灶被分类为升级(DWI评分3且DCE阳性)或非升级(DWI评分4,无论DCE状态)
- 整体PI-RADS分类的观察者间一致性为中等至高度
诊断标准与关键数值
- csPCa总体检出率为47%(176/375病灶)
- 升级PI-RADS 4病灶的csPCa检出率在阅片者间为39%至68%
- 非升级PI-RADS 4病灶的csPCa检出率在阅片者间为63%至81%
- PI-RADS 4亚分类的观察者间一致性仅为一般至中等(Gwet's AC1范围0.29-0.57)
临床应用与阅片要点
- 阅片时不应过度依赖PI-RADS 4升级亚分类来预测csPCa风险
- DWI评分为4的非升级病灶生物学意义相对明确,但升级病灶的判读存在较大变异
- 报告中应意识到不同阅片者对DCE阳性和DWI评分的判定差异可能影响升级分类
局限性
- 回顾性单中心研究设计
- 病灶为预定位后重新评分,可能不能完全反映真实临床首次阅片情景
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To evaluate inter-reader reproducibility of PI-RADS v2.1 upgrading rule subcategorization in prelocalized MRI-visible peripheral zone (PZ) lesions and assess its association with lesion-level clinically significant prostate cancer (csPCa) yield at MRI-targeted biopsy.
METHODS: This retrospective single-center lesion-level study included 310 men with 375 MRI-visible PZ lesions who underwent 3-T multiparametric MRI followed by MRI-TRUS fusion-targeted biopsy. Three radiologists independently rescored prelocalized lesions using PI-RADS v2.1. PI-RADS 4 lesions were classified as upgraded when assigned DWI score 3 with positive dynamic contrast-enhanced (DCE) imaging, or non-upgraded when assigned DWI score 4 regardless of DCE status. csPCa was defined as ISUP grade group ≥ 2. Inter-reader agreement was assessed, and generalized estimating equations were used to account for within-patient clustering.
RESULTS: csPCa was present in 176/375 lesions (47 %). Inter-reader agreement was moderate-to-substantial for overall PI-RADS categorization, but only fair-to-moderate for PI-RADS 4 subcategorization (Gwet's AC1 range, 0.29-0.57). Across readers, csPCa yield ranged from 39 % to 68 % for upgraded PI-RADS 4 lesions and from 63 % to 81 % for non-upgraded lesions. The magnitude and significance of this subgroup contrast varied by reader.
CONCLUSION: In this multireader, lesion-level, targeted-biopsy cohort, subcategorization of the PI-RADS 4 upgrading rule showed limited reproducibility. Although nonupgraded lesions generally showed higher csPCa yield, subgroup-specific estimates were reader-dependent, supporting cautious interpretation of this split.
引用
- Coelho, Mussi, Moreira, et al. Limited reproducibility of PI-RADS v2.1 upgrading rule subcategorization in MRI-visible peripheral zone lesions: A lesion-level targeted-biopsy study. Eur J Radiol. 2026. PMID: 42302440. doi:10.1016/j.ejrad.2026.113004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。